Danazol-induced hepatocellular carcinoma in a patient with hereditary angioedema

Journal of Gastrointestinal Cancer

Volumn 43, Issue SUPPL. 1, 2012, Pages

  Thoufeeq, Muhammed Hameed ^a   Ishtiaq, Javaid ^b   Abuzakouk, Mohamed ^c  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b DIANA PRINCESS OF WALES HOSPITAL   (United Kingdom)

^c HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; DANAZOL; ANTIESTROGEN;

ABDOMINAL PAIN; ACUTE ABDOMEN; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIONEUROTIC EDEMA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG INDUCED CANCER; DRUG WITHDRAWAL; ECHOGRAPHY; FACE; FAMILY HISTORY; HAND; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOTENSION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER NODULE; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RECURRENT DISEASE; SWELLING; VOMITING; ABDOMINAL RADIOGRAPHY; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE TITRATION; OUTCOME ASSESSMENT; PATIENT REFERRAL; TREATMENT OUTCOME; TUMOR BIOPSY; ANGIOEDEMAS, HEREDITARY; CARCINOMA, HEPATOCELLULAR; CHEMICALLY INDUCED; LIVER NEOPLASMS; PROGNOSIS;

AGED; ANGIOEDEMAS, HEREDITARY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DANAZOL; ESTROGEN ANTAGONISTS; HUMANS; LIVER NEOPLASMS; MALE; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84887401488     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-012-9402-5     Document Type: Article

References (18)

1. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417-29.
2. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-36.
3. Farkas H, Czaller I, Csuka D, Vas A, Valentin S, Varga L, et al. The effect of long-term danazol prophylaxis on liver function in hereditary angioedema - a longitudinal study. Eur J Clin Pharmacol. 2010;66(4):419-26.
4. Helsing P, Nielsen EW. Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema. Acta Derm Venereol. 2006;86(3):272-3.
5. Crampon D, Barnoud R, Durand M, Ponard D, Jacquot C, Sotto JJ, et al. Danazol therapy: an unusual aetiology of hepatocellular carcinoma. J Hepatol. 1998;29(6):1035-6.
6. Alvarez GC, Gomez-Galicia D, Rodriguez-Fragoso L, Marina VM, Dorantes LC, Sanchez-Aleman M, et al. Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin. Ann Hepatol. 2011;10(4):458-68.
7. Sweeney EC, Evans DJ. Hepatic lesions in patients treated with synthetic anabolic steroids. J Clin Pathol. 1976;29(7):626-33.
8. Weill BJ, Menkes CJ, Cormier C, Louvel A, Dougados M, Houssin D. Hepatocellular carcinoma after danazol therapy. J Rheumatol. 1988;15(9):1447-9.
9. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg. 1988;208(5):558-64.
10. Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol. 2008;21(4):491-7.
11. Bork K, Pitton M, Harten P, Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet. 1999;353(9158):1066-7.
12. Buamah PK. An apparent danazol-induced primary hepatocellular carcinoma: case report. J Surg Oncol. 1985;28(2):114-6.
13. Confavreux C, Seve P, Broussolle C, Renaudier P, Ducerf C. Danazol-induced hepatocellular carcinoma. QJM. 2003;96(4):317-8.
14. Monnier N, Ponard D, Duponchel C, Csopaki F, Bouillet L, Tosi M, et al. Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma. Mol Immunol. 2006;43(14):2161-8.
15. Nagasue N, Kohno H. Hepatocellular carcinoma and sex hormones. HPB Surg. 1992;6(1):1-6.
16. Nagasue N, Chang YC, Hayashi T, Galizia G, Kohno H, Nakamura T, et al. Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann Surg. 1989;209(4):424-7.
17. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol. 2004;77(3):257-67.
18. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24.